Androgen therapy and atherosclerotic cardiovascular disease. - Wikidata - awgldk - TriplyDB

Androgen therapy and atherosclerotic cardiovascular disease.

Androgen therapy and atherosclerotic cardiovascular disease.

http://www.wikidata.org/entity/Q36766910

about

Polychlorinated biphenyls and links to cardiovascular disease Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen.Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression.The genetic variation rs6903956 in the novel androgen-dependent tissue factor pathway inhibitor regulating protein (ADTRP) gene is not associated with levels of plasma coagulation factors in the Singaporean Chinese.Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.Association between Androgenic Hormone Levels and Left Ventricular Ejection Fraction The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State.The influence of concomitant use of alcohol, tobacco, cocaine, and anabolic steroids on lipid profiles of Brazilian recreational bodybuilders.

P2860

Q28391417-897D9455-4C71-492E-9CDB-18A6FE92C6B6 Q34114338-D26A80FE-44AC-4DFE-8641-26D5F6F05CD7 Q35485855-D1BC92B9-C4C9-4EFA-B9D3-58418119EA69 Q37452288-5A7B2C5B-934A-4007-8B21-D15A71547BA0 Q37569499-D5AF62BE-E7EF-4525-9F7E-669085EC4011 Q37600356-EFDC5B40-ADCF-4A1F-AF2D-D8F3E3128825 Q42189969-02642CD9-FFB5-42C1-ABC3-210BD3557BEA Q47133443-A322514E-5618-4E08-B764-3B5E6E17E179 Q47879422-F9B8A9B8-F1B7-4DA2-8883-10DEDF43D2AD

P2860

Androgen therapy and atherosclerotic cardiovascular disease.

http://www.wikidata.org/entity/Q36766910

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Androgen therapy and atherosclerotic cardiovascular disease.

@ast

Androgen therapy and atherosclerotic cardiovascular disease.

@en

type

label

Androgen therapy and atherosclerotic cardiovascular disease.

@ast

Androgen therapy and atherosclerotic cardiovascular disease.

@en

prefLabel

Androgen therapy and atherosclerotic cardiovascular disease.

@ast

Androgen therapy and atherosclerotic cardiovascular disease.

@en

P1433

Q36766910-0BEB8FD0-DE1A-474E-9B32-47F7453B7464

P1476

Q36766910-3A7A48DE-FA3D-48A7-8908-4608507165EC

P2093

Q36766910-A8516B02-876B-498C-8FA9-048B4CEA1ED3

P2860

Q36766910-06DF254B-98E4-4F9C-A0B3-AB92623E8B37

Q36766910-0B23BA8D-EA03-45F9-9A46-CE90454C655F

Q36766910-0B4DD545-E559-4890-B368-D198A92AC143

Q36766910-0D08925D-73E6-4EB0-B485-75362E41413F

Q36766910-1C97EFF6-32A4-4C92-B72C-387462BF1E7B

Q36766910-1EBC6114-8136-4F96-93D6-D3BE2C3055CC

Q36766910-204814AE-9B4C-4BFA-81CC-A4DBADBE711A

Q36766910-2458D681-D9A3-4696-BD0F-8242D4760F2A

Q36766910-24D42AB3-C054-477C-9CC7-5DC8E27DB37F

Q36766910-275431E8-4DEA-48E3-BF69-E218393984F3

P304

Q36766910-24FC0E18-FF71-4A73-8FD9-8ED4E9A4DAF3

P31

Q36766910-F596BBBC-829C-41C1-B7B8-5EC9F7685922

P356

Q36766910-3132204A-BE40-4ACC-A341-F3ABAE7FAC78

P407

Q36766910-8674A35C-D139-4ABF-961D-50F040CEE904

P433

Q36766910-D5E7AB1C-4E83-47E9-AD7E-A90C1383CC03

P478

Q36766910-212566E3-B069-484E-B88B-3E93D70ACEE9

P50

Q36766910-3B42B0D6-DD58-451E-8E44-0A60C6D71C3C

Q36766910-E2D28B1B-6AFC-41DC-9D56-72A14B3553FE

P577

Q36766910-89DC6151-84AB-4019-A6BA-0DDDB6DEEAA6

P5875

Q36766910-C999D7E2-F0CF-4144-AECA-0A440FF44A83

P698

Q36766910-C20CF9BA-2106-485C-8395-7F5512266A67

P921

Q36766910-420A79A9-C83E-4921-8E1E-F3D4A1DFE82F

Q36766910-473BAA1C-2F77-4E7C-B075-1CB86DFFA2B9

Q36766910-9769C302-EE29-47D8-A2E9-FDDEC19FE7FD

Q36766910-BA22F099-8573-473D-AF12-EE7218AFAA9D

P932

Q36766910-26D18E6E-7CBB-4EE5-B1B3-52776140D971

P356

VHRM.2008.04.01.11

P1433

Vascular Health and Risk Management

P1476

Androgen therapy and atherosclerotic cardiovascular disease

@en

P2093

A K Heather

http://www.w3.org/2001/XMLSchema#string

P2860

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

Atherosclerosis — An Inflammatory Disease

Androgen receptor defects: historical, clinical, and molecular perspectives

Acute anti-ischemic effect of testosterone in men with coronary artery disease

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites.

Rapid effects of androgens in macrophages.

Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase.

Androgen physiology.

Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis.

Mortality and morbidity in transsexual subjects treated with cross-sex hormones.

P304

11-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.2008.04.01.11

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Lucinda S McRobb

Kristine McGrath

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51404161

http://www.w3.org/2001/XMLSchema#string

P698

18629352

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

arteriosclerosis

cardiovascular disease

P932

2464747

http://www.w3.org/2001/XMLSchema#string